Randomized study of vinorelbine-gemcitabine versus vinorelbine-carboplatin in patients with advanced non-small cell lung cancer

Lung Cancer

Volumn 49, Issue 2, 2005, Pages 233-240

  Tan, E H ^a   Szczesna, A ^b   Krzakowski, M ^c   Macha, H N ^d   Gatzemeier, U ^e   Mattson, K ^f   Wernli, M ^g   Reiterer, P ^h   Hui, R ⁱ   Von Pawel, J ^j   Bertetto, O ^k   Pouget, J C ^l   Burillon, J P ^l   Parlier, Y ^l   Abratt, R ^m  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b III Oddzial Chorob Pluc   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d LUNGENKLINIK HEMER   (Germany)

^e KRANKENHAUS GROSSHANSDORF   (Germany)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g CANTONAL HOSPITAL AARAU   (Switzerland)

^h Mazaryk Hospital   (Czech Republic)

ⁱ WESTMEAD HOSPITAL   (Australia)

^j Asklepios Fachkliniken   (Germany)

^k Azienda Ospedaliera di Torino   (Italy)

^l INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^m UNIVERSITY OF CAPE TOWN   (South Africa)

more..

Author keywords

Non small cell lung cancer; Progression free survival; Tolerance

Indexed keywords

CARBOPLATIN; GEMCITABINE; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFECTION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; VEIN DISEASE; VOMITING;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DEOXYCYTIDINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERNATIONAL AGENCIES; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE;

EID: 22044445819     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.03.029     Document Type: Article

References (22)

1. T. Le Chevalier, D. Brisgand, and J.Y. Douillard Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of an European multicenter trial including 612 patients J Clin Oncol 12 1994 360 367
2. A.J. Wozniak, J.J. Crowley, and S.P. Balcerzak Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung caner: a Southwest Oncology Group study J Clin Oncol 16 1998 2459 2465
3. A. Masotti, G. Borzellino, and G. Zannini Efficacy and toxicity of vinorelbine-carboplatin combinations in the treatment of advanced adenocarcinoma or large cell carcinoma of the lung Tumori 81 1995 112 116
4. M. Colleoni, L. Boni, and G. Vicario A dose-escalating study of carboplatin combined with vinorelbine in non-small cell lung cancer Oncology 53 1996 364 368
5. C. Santomaggio, E. Tucci, and M. Rinaldini Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: a multicenter phase II study Am J Clin Oncol 21 1998 67 71
6. ®, NVB) + carboplatin in advanced non-small-cell lung cancer (NSCLC) Eur J Cancer 33 Suppl. 8 1997 241
7. L. Horvath, M. Boyer, and S. Clarke Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer. A single-institution phase II study Lung Cancer 32 2001 173 178
8. N. Katakami, T. Sugiura, and T. Nogami Combination of gemcitabine and vinorelbine for patients in stage IIIB-IV non-small-cell lung cancer: a phase II study of the West Japan Thoracic Oncology Group (WJTOG) 9908 Lung Cancer 43 2004 93 100
9. Y. Horio, N. Yamamoto, and Y. Takada A randomised phase II study of carboplatin/gemcitabine (CG) versus vinorelbine/gemcitabine (VG) in patients with advanced non-small-cell lung cancer, West Japan Thoracic Oncology group (WJTOG) 0104 J Clin Oncol 22 2003 646 abstract #2600
10. E. Laack, T. Mende, and J. Benk Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small-cell lung cancer: a phase II trial Eur J Cancer 37 2001 583 590
11. C. Gridelli, G. Gallo, and F.A. Shepherd Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN investigators and the National Cancer Institute of Canada clinical trials group J Clin Oncol 21 2003 3025 3034
12. C. Gridelli, L. Frontini, and F. Perrone Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses Br J Cancer 83 2000 707 714
13. P.A. Pizzo Management of fever in patients with cancer and treatment-induced neutropenia N Engl J Med 328 1993 1323 1332
14. F. Von Bültzingslöwen Vinorelbine and carboplatinum in patients with stage IIIB/IV non-small cell lung cancer Ann Oncol 11 Suppl. 4 2000 abstract #543
15. R.C. Lilenbaum, R. Cano, and M.A. Schwartz Gemcitabine and vinorelbine in advanced non-small cell lung carcinoma Cancer 88 2000 557 562
16. E.E. Vokes Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer Oncology 9 1995 565 577
17. J.H. Schiller Platin or no platin? That is the question J Clin Oncol 21 2003 3009 3010
18. F. Greco, J.R. Gray, and D.S. Thompson Prospective randomised study of four novel chemotherapy regimens in patients with advanced non-small-cell lung carcinoma Cancer 95 2002 1279 1285
19. V. Georgoulias, E. Papadakis, and A. Alexopoulos Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial Lancet 357 2001 1478 1484
20. P. Kosmidis, N. Mylonakis, and C. Nicolaides Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomised trial J Clin Oncol 20 2002 3578 3585
21. D.J. Pfister, D.H. Johnson, and C.G. Azzoli American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003 J Clin Oncol 22 2004 330 353
22. M.E.R. O'Brien, A. Szczesna, and H. Karnicka Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small cell lung cancer: results of a multicentre phase II study Ann Oncol 15 2004 921 927